{
  "meta": {
    "results": {
      "skip": 0,
      "limit": 10,
      "total": 45
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Princeton",
      "reason_for_recall": "Presence of N-Nitrosodimethylamine (NDMA) impurity",
      "address_1": "One Merck Drive",
      "address_2": "",
      "product_quantity": "5,432 bottles",
      "code_info": "Lot numbers: AB1234, CD5678, EF9012",
      "center_classification_date": "20230615",
      "distribution_pattern": "Nationwide",
      "state": "NJ",
      "product_description": "Valsartan Tablets USP, 160 mg, 90 count bottles",
      "report_date": "20230622",
      "classification": "Class II",
      "openfda": {
        "application_number": ["ANDA090802"],
        "brand_name": ["VALSARTAN"],
        "generic_name": ["VALSARTAN"],
        "manufacturer_name": ["Mylan Pharmaceuticals Inc."]
      },
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "recall_number": "D-0001-2023",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "91234",
      "recall_initiation_date": "20230610",
      "postal_code": "08540",
      "voluntary_mandated": "Voluntary: Firm Initiated",
      "status": "Ongoing"
    },
    {
      "country": "United States",
      "city": "New York",
      "reason_for_recall": "Contamination with foreign substance",
      "product_quantity": "10,000 units",
      "classification": "Class I",
      "product_description": "Metformin Hydrochloride Extended-Release Tablets, 500 mg",
      "report_date": "20230515",
      "recalling_firm": "Generic Pharma Corp",
      "recall_number": "D-0002-2023",
      "recall_initiation_date": "20230510",
      "status": "Completed"
    }
  ]
}
